Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Iovance Biotherapeutics (Silver).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

VJVirtual | Lineage plasticity in lung cancer: biological & therapeutic implications

Triparna Sen, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, discusses lineage plasticity and its implication in the development of lung cancer, as well as resistance to therapeutics. The results of an in-depth characterization of neuroendocrine transformation in lung cancer is presented and highlight a new landscape of potential drivers and targetable mutations of neuroendocrine transformation in lung cancer. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.